Industry gave $6.5 billion to health providers

Money flows from the medical industry to doctors and hospitals. Is this good for patient care? It is probably a yes and no answer.

Read the article below from the Los Angeles Times, dated July 2, 2015

BY CHAD TERHUNE

Doctors and teaching hospitals received $6.5 billion last year from drug companies and medical device firms for research, consulting and other reasons, new federal data show.

The details published by the Obama administration mark the second batch of data on industry ties to medical providers.

As part of the Affordable Care Act, federal health officials released information last year on payments made for five months of 2013. The latest data cover all of 2014.

Consumers can look up information on 607,000 U.S. physicians and 1,121 teaching hospitals using the federal government’s database at openpaymentsdata.cms.gov  .

“This is part of our larger effort to open up the healthcare system to consumers by providing more information to help in their decision making,” said Andy Slavitt, acting administrator at the Centers for Medicare and Medicaid Services.

There were 1,444 companies that made payments in 2014. About half of the $6.5 billion in payouts were classified for research purposes. More than $2.5 billion was labeled general payments, and $703 million represented ownership or investment interests held by medical providers.

Consumer advocates and federal lawmakers have pushed for these disclosures for years out of concern that conflicts of interest in the medical profession are jeopardizing patient care and costing taxpayer-funded health programs.

Health-policy experts have warned that these industry ties, including speaking and consulting fees, luxury trips and meals, can lead to patients getting the wrong drugs or medical procedures.

Those decisions can harm patients and drive up the nation’s $3-trillion medical tab, experts warn.

The American Medical Assn. cautioned patients against drawing too many conclusions from the data.

The physicians group said the data can be inaccurate and misleading, and that relationships with drug and device firms can foster breakthroughs in treatment. chad.terhune@latimes.com 

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers:

The Dennis L. David Insurance Agency | Long Term Care Insurance, Los Angeles Medical Insurance, Anthem Blue Cross Healthcare Insurance, Whole & Term Life Insurance Policies, Cigna, Disability Insurance, Blue Shield of CA, Group Health Plans, Aetna, Group Medical Insurance, Skilled Nursing Insurance, Medicare Supplement Insurance, Medicare Part D Prescription Drug Plans, In-Home Care, Disabled Work Insurance, Disability Benefits, Culver City Health & Life Insurance, Family & Individual Health Insurance, Health Care Reform & Affordable Care Act Assistance, Obamacare, Covered CA Health Insurance, Health Plans, Kaiser Insurance, Genworth Life, John Hancock Life, Culver City Long Term Care & Disability, Employee Benefits, Beverly Hills, Hollywood, West Hollywood, Santa Monica, Pacific Palisades, Marina Del Rey, West Los Angeles, Los Angeles, El Segundo, Sherman Oaks, Encino, Los Angeles, Manhattan Beach, Los Angeles County CA, California

CA Insurance License Number:  0668857

TX Insurance License Number:  1774174